REQUEST A DEMO
Total
USD $0.00
Search more companies

Glenmark - Pharmaceuticals Ecuador S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Glenmark - Pharmaceuticals Ecuador S.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Glenmark - Pharmaceuticals Ecuador S.A. is based in Ecuador, with the head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on March 15, 2017. It currently has a total number of 21 (2024) employees. From the latest financial highlights, Glenmark - Pharmaceuticals Ecuador S.A. reported a net sales revenue drop of 39% in 2024. Its’ total assets recorded a growth of 16.05%. In 2024, Glenmark - Pharmaceuticals Ecuador S.A.’s net profit margin decreased by 29.37%.

Headquarters
Av. Simon Bolivar Km. 711860, Ekopark Bldg. , Floor 703
Quito; Pichincha;

Contact Details: Purchase the Glenmark - Pharmaceuticals Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Glenmark - Pharmaceuticals Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Glenmark - Pharmaceuticals Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Glenmark - Pharmaceuticals Ecuador S.A. report to view the information.
Incorporation Date:
March 15, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Glenmark - Pharmaceuticals Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-39%
Total operating revenue
-39%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-867.5%
Total assets
16.05%
Total equity
-93.57%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-29.37%
Return on Equity (ROE)
-1499.59%
Debt to Equity Ratio
268.82%
Quick Ratio
-0.73%
Cash Ratio
-0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?